Bayesian Capital Management’s Idexx Laboratories IDXX Stock Holding History

Bayesian Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$394K	Buy	+749	New	+$420K	0.25%	113
2025 Q4	–	Sell	-7,200	Closed	-$4.6M	–	320
2025 Q3	$4.6M	Buy	7,200 +6,276	+679%	+$3.81M	0.94%	9
2025 Q2	$496K	Sell	924 -4,122	-82%	-$1.97M	0.08%	280
2025 Q1	$2.12M	Buy	+5,046	New	+$2.19M	0.35%	76
2024 Q4	–	Sell	-533	Closed	-$269K	–	828
2024 Q3	$269K	Buy	+533	New	+$259K	0.03%	498
2022 Q4	–	Sell	-2,710	Closed	-$883K	–	888
2022 Q3	$883K	Buy	+2,710	New	+$995K	0.18%	154
2021 Q2	–	Sell	-3,189	Closed	-$1.56M	–	515
2021 Q1	$1.56M	Buy	3,189 +1,689	+113%	+$846K	0.36%	65
2020 Q4	$750K	Buy	+1,500	New	+$671K	0.2%	151
2018 Q3	–	Sell	-2,300	Closed	-$501K	–	705
2018 Q2	$501K	Buy	+2,300	New	+$474K	0.11%	263
2017 Q3	–	Sell	-4,700	Closed	-$759K	–	555
2017 Q2	$759K	Sell	4,700 -1,300	-22%	-$211K	0.28%	120
2017 Q1	$928K	Buy	+6,000	New	+$827K	0.44%	51
2016 Q4	–	Sell	-6,500	Closed	-$733K	–	644
2016 Q3	$733K	Sell	6,500 -2,100	-24%	-$221K	0.48%	57
2016 Q2	$799K	Buy	8,600 +3,900	+83%	+$335K	0.48%	42
2016 Q1	$368K	Buy	+4,700	New	+$338K	0.35%	100

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bayesian Capital Management's IDXX Position: Q2 2026 in Review

Bayesian Capital Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 749 shares worth $394K. The stake represents 0.25% of the portfolio and ranks #113 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in IDXX as recently as Q3 2025.

Bayesian Capital Management first reported a position in IDXX in Q1 2016 and has held it in 14 quarters since. The position peaked at $4.6M in Q3 2025. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Bayesian Capital Management held 749 shares of Idexx Laboratories worth $394K as of Q2 2026.
Idexx Laboratories was a new Bayesian Capital Management position in Q2 2026.
Idexx Laboratories made up 0.25% of Bayesian Capital Management's portfolio in Q2 2026, its #113 holding.
Bayesian Capital Management first reported a position in Idexx Laboratories in Q1 2016 and has held it in 14 quarters since.
Bayesian Capital Management's Idexx Laboratories position peaked at $4.6M in Q3 2025.
1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.